Literature DB >> 7230613

Leukopenia, hypoxia, and complement function with different hemodialysis membranes.

A I Jacob, G Gavellas, R Zarco, G Perez, J J Bourgoignie.   

Abstract

Complement activation during exposure of plasma to cuprophan has been postulated to cause leukopenia and hypoxia in hemodialysis patients. To determine if hypoxia is related to leukopenia and if complement activation leads to a depletion of functional complement components, we dialyzed four patients three times sequentially against each of four types of membranes: cuprophan, regenerated cellulose, cellulose acetate, and polyacrilonitrile. Within 20 min there was a marked leukopenia with cuprophan from 5541 +/- 376 to 1216 +/- 94 (P less than 0.001) and with regenerated cellulose from 5541 +/- 411 to 1533 +/- 203 (P less than 0.001). With cellulose acetate, the change from 5558 +/- 400 to 3783 +/- 341 (P less than 0.001) was less dramatic, and with polyacrilonitrile the fall from 5591 +/- 381 to 464 +/- 401 (P less than 0.02) was minimal. After 2 and 4 hours of dialysis, a rebound leukocytosis was seen with cuprophan, regenerated cellulose, and cellulose acetate, but not with polyacrilonitrile. Transient thrombocytopenia occurred with cuprophan and regenerated cellulose. In spite of the variable degree of leukopenia, all membranes induced a similar and significant hypoxia, which was progressive throughout dialysis, even during the rebound leukocytosis. After 4 hours, the mean PO2 ranged from 91 to 93 mm Hg with all membranes. Functional hemolytic titers of whole complement, C3, C5, and C4 were normal prior to hemodialysis and failed to decrease after 4 hours with any membrane. It is concluded that hemodialysis leukopenia is membrane-dependent and is not the cause of hypoxia. In addition, hemodialysis complement activation does not lead to functional complement depletion and is of no clinical significance.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7230613     DOI: 10.1038/ki.1980.164

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

Review 1.  Effect of uremia and its treatment on pulmonary function.

Authors:  D J Prezant
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  Inert gas analysis of ventilation-perfusion matching during hemodialysis.

Authors:  D D Ralph; S M Ott; D J Sherrard; M P Hlastala
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

3.  Leukopenia with different regenerated haemodialysis membranes.

Authors:  A Ksiaźek; G Sokołowska; K Marczewski; J Solski
Journal:  Int Urol Nephrol       Date:  1984       Impact factor: 2.370

4.  Continuous arteriovenous hemodialysis: an alternative therapy for acute renal failure associated with critical illness.

Authors:  R T Gibney; D E Stollery; R E Lefebvre; C J Sharun; P Chan
Journal:  CMAJ       Date:  1988-11-01       Impact factor: 8.262

5.  Influence of prostacyclin infusion on haemodialysis efficiency and blood cells.

Authors:  M Kuźniewski; W Sułowicz
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

6.  Intradialytic Hypoxemia and Clinical Outcomes in Patients on Hemodialysis.

Authors:  Anna Meyring-Wösten; Hanjie Zhang; Xiaoling Ye; Doris H Fuertinger; Lili Chan; Franz Kappel; Mikhail Artemyev; Nancy Ginsberg; Yuedong Wang; Stephan Thijssen; Peter Kotanko
Journal:  Clin J Am Soc Nephrol       Date:  2016-03-02       Impact factor: 8.237

Review 7.  A review of continuous renal replacement therapy.

Authors:  C G Flynn
Journal:  Ir J Med Sci       Date:  1994-07       Impact factor: 1.568

8.  Medium cut-off membranes - closer to the natural kidney removal function.

Authors:  Carina Zweigart; Adriana Boschetti-de-Fierro; Michael Hulko; Lars-Göran Nilsson; Werner Beck; Markus Storr; Bernd Krause
Journal:  Int J Artif Organs       Date:  2017-05-26       Impact factor: 1.595

9.  Older Age and High Serum Ferritin Levels Associated With the Risk of Chronic Cytopenia in Hemodialysis Patients.

Authors:  Yu-Ting Lee; Wei-Yu Wang; Chin-Ho Kuo; Ming-Yang Lee; Yin-Che Lu; Chih-Yen Hsiao; Yueh-Han Hsu; Peir-Haur Hung
Journal:  Front Med (Lausanne)       Date:  2020-10-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.